Verbesserung der Prognose und Lebensqualität junger Darmkrebs-Patientinnen und -Patienten: Tertiärprävention durch Multimarker-Modelle und ernährungsmedizinische Interventionen

Overview
Related items

Ein wesentliches Ziel nach der erfolgreichen Darmkrebsbehandlung ist es ein Wiederauftreten der Erkrankung (ein Rezidiv) zu verhindern bzw. wenn es doch dazu kommt das Rezidiv früh und gut behandelbar zu erkennen.

SEEK ID: https://ldh.uksh.imise.uni-leipzig.de/projects/8

Public web page: https://outlive-crc.de/

NFDI4Health PALs: No PALs for this Project

Project created: 30th Jul 2025

Extended Metadata (Nfdi4Health MDS 3.3)

Expand All Collapse All

Id of the project(*) : nfdi4health-30001

Resource classification(*)

Type of the resource : Study

Title(s)/name(s) of the Project

Title/name : Verbesserung der Prognose und Lebensqualität junger Darmkrebs-Patientinnen und -Patienten: Tertiärprävention durch Multimarker-Modelle und ernährungsmedizinische Interventionen
Language of the title/name : German

Acronym(s) of the Project

Acronym : OUTLIVE-CRC
Language of the acronym : English

Description(s) of the Project

Description : Um Rezidive von Darmkrebs in einem möglichst frühen Stadium zu erkennen und Personen mit einem erhöhten Risiko zu erkennen, arbeiten wir an der Entwicklung und Verfeinerung modernster Analyseverfahren. Dazu soll ein neuartiges, so genanntes „Multimarker-Risikopanel“ entwickelt werden. Hierunter versteht man die zusammenfassende Betrachtung verschiedener klinischer Werte und Labor-Messverfahren, um das individuelle Risiko einer Person für ein Rezidivs zu ermitteln.
Language of the description : German

Keyword(s) describing the Project

Keyword(*) : Darmkrebs, Tertiärprävention, Liquid Biopsy

Language(s) of the project : German

Web page of the project : https://outlive-crc.de/

Contributor(s) of the Project

Is it a personal or organisational contribution?(*) : Organisational
Details about the contributing organisation(s)/institution(s)/group(s)
Contributor type(*) : Creator/Author
Funding identifier(s) : BMFTR
Name of the organisation/institution/group(*) : Not specified
Details about the contributing person(s)
Contributor type(*) : Not specified
Given name(*) : Not specified
Family name(s)(*) : Not specified
Digital identifier(s)
Identifier(*) : Not specified
Scheme(*) : Not specified
Email address : Not specified
Phone number : Not specified
Organisation(s) associated with the contributor
Name(*) : Not specified
Address : Not specified
Web page : Not specified
Digital identifier(s)
Identifier(*) : Not specified
Scheme(*) : Not specified

Alternative identifiers

Type of the registry(*) : DRKS
Identifier(*) : DRKS00031028

Characteristics of the Project

Is it an interventional or non-interventional Project? : Non-interventional
Specification of the type of the Project
Interventional Project type : []
Non-interventional Project type : []
Primary health condition(s) or disease(s) considered in the Project
Primary health condition or disease name(*) : Darmkrebs
Terminology/classification(*) : ICD-10
Code of the health condition or disease : C18
Groups of diseases or conditions(*)
Which groups of diseases or conditions were the data collected on? : Neoplasms (II)
On which diseases or conditions were the data collected? : []
Collects mortality data? : Not specified
Administrative information about the Project
Status of the ethics committee approval : Request for approval submitted, approval granted
Overall Project status : Ongoing (II): Recruitment and data collection ongoing
Participants enrolled by invitation? : Not specified
Start date : Not specified
End date : Not specified
Mono- or multicentric? : Not specified
Number of centers : Not specified
One or more data providers? : Not specified
Number of data providers : Not specified
Primary subject(*) : Person
Eligibility criteria for Project participants
Eligibility criteria: Minimum age
Minimum eligible age(*) : Not specified
Unit of age(*) : Not specified
Eligibility criteria: Maximum age
Maximum eligible age(*) : 49
Unit of age(*) : Years
Eligible gender : []
Inclusion criteria : Not specified
Exclusion criteria : Not specified
Population of the Project(*)
Coverage : Not specified
Country(ies) : Germany
Region(s) and/or city(ies) : Not specified
Interventions of the Project
Name of the intervention(*) : Not specified
Type of the intervention : Not specified
Additional information about the intervention : Not specified
Name(s) of the arm(s) associated with the given intervention : Not specified
Exposures of the Project
Name of the exposure : Not specified
Type of the exposure : Not specified
Additional information about the exposure : Not specified
Name(s) of the group(s) associated with the given exposure : Not specified
Outcome measures in the Project
Name of the outcome measure(*) : Not specified
Description of the outcome measure : Not specified
Type of the outcome measure : Not specified
Time point(s) of assessment : Not specified
Additional information about the Project : Not specified
Additional assessments/measurements in the Project : []
Data sharing strategy of the Project(*)
Is it planned to share the data?(*) : Not specified
Supporting documents available in addition to the data : []
When and for how long will the data be available? : Not specified
Criteria for data access : Not specified
Additional information about data sharing : Not specified
DataSHIELD/Opal infrastructure available? : Not specified
Link to data request application : Not specified
Web page with additional information about data sharing : Not specified
Record linkage possible? : false
Non-interventional aspects of the Project
Temporal design : []
Target follow-up duration of the Project
Target follow-up duration(*) : Not specified
Unit of time(*) : Not specified
Number of follow-ups conducted : Not specified
Biosamples retained in a biorepository : []
Specific types of retained biosamples : Not specified
Interventional aspects of the Project
Numerical phase : Not specified
Masking of intervention(s) assignment
Masking implemented? : Not specified
Who is masked? : []
Additional information about masking : Not specified
Type of allocation of participants to an arm : Not specified
Off-label use of a drug product : Not specified

Verbesserung der Prognose und Lebensqualität junger Darmkrebs-Patientinnen und -Patienten: Tertiärprävention durch Multimarker-Modelle und ernährungsmedizinische Interventionen

Related items